SCI时时刷

search
+
Association between early anti-cytomegalovirus therapy and the incidence of chronic graft-versus-host disease
Association between early anti-cytomegalovirus therapy and the incidence of chronic graft-versus-host disease
Ganciclovir and foscarnet are two representative anti-cytomegalovirus (CMV) agents. A previous regional study revealed a l...
Successful complete remission after induction therapy with CPX-351 for acute myeloid leukemia with myelodysplasia-related changes accompanied by double-minute chromosomes and MYC gene amplification
Successful complete remission after induction therapy with CPX-351 for acute myeloid leukemia with myelodysplasia-related changes accompanied by double-minute chromosomes and MYC gene amplification
Cite this articleSaburi, M., Nishikawa, T., Kawano, K. et al. Successful complete remission after induction therapy with C...
Iron deficiency and phlebotomy in patients with polycythemia vera
Iron deficiency and phlebotomy in patients with polycythemia vera
Polycythemia vera (PV) is a myeloproliferative neoplasm that is associated with an elevated risk of thrombosis. Treatment ...
CD34+ and CD34− MM cells show different immune-checkpoint molecule expression profiles: high expression of CD112 and CD137 ligand on CD34+ MM cells
CD34+ and CD34− MM cells show different immune-checkpoint molecule expression profiles: high expression of CD112 and CD137 ligand on CD34+ MM cells
Despite the introduction of new drugs, multiple myeloma (MM) still remains incurable. We previously reported that CD34+ MM...
Neoplastic plasma cells demonstrating phagocytosis and clasmatosis
Neoplastic plasma cells demonstrating phagocytosis and clasmatosis
Conflict of interest The authors have no conflict of interest. ...
A phase 1/2 study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia
A phase 1/2 study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia
This interim analysis of a phase 1/2, open-label, single-arm study assessed the safety, efficacy, and pharmacokinetics of ...
The in vitro cross-reactivity and blood coagulation potential of recombinant porcine factor VIII in Japanese patients with acquired hemophilia A
The in vitro cross-reactivity and blood coagulation potential of recombinant porcine factor VIII in Japanese patients with acquired hemophilia A
Recombinant porcine factor VIII (rpFVIII) is a hemostatic agent for acquired hemophilia A (AHA). Cross-reaction of auto-an...
Factor X consumption attenuates the coagulation effect of emicizumab: a case of severe hemophilia A treated with emicizumab and factor VIII-bypassing agents
Factor X consumption attenuates the coagulation effect of emicizumab: a case of severe hemophilia A treated with emicizumab and factor VIII-bypassing agents
In patients with hemophilia A with inhibitor (PwHA-I), emicizumab drastically reduces bleeding events. However, few studie...
Misleading antigenic von Willebrand factor levels in acquired von Willebrand syndrome secondary to monoclonal gammopathy of undetermined significance
Misleading antigenic von Willebrand factor levels in acquired von Willebrand syndrome secondary to monoclonal gammopathy of undetermined significance
In the diagnosis and treatment of acquired von Willebrand syndrome (AVWS), von Willebrand factor (VWF) antigen levels (VWF...
Quizartinib with donor lymphocyte infusion for post-transplant relapse of FLT3-ITD-positive acute myeloid leukemia
Quizartinib with donor lymphocyte infusion for post-transplant relapse of FLT3-ITD-positive acute myeloid leukemia
FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD)-positive acute myeloid leukemia (AML) has a poor prognos...
Clinical characteristics in adolescents and young adults with polycythemia vera and essential thrombocythemia in Japan
Clinical characteristics in adolescents and young adults with polycythemia vera and essential thrombocythemia in Japan
We report the first large-scale retrospective cohort study on adolescent and young adult (AYA) polycythemia vera (PV) and ...
Assay variables and early clinical evaluation of low-angle light scattering for platelet function analysis
Assay variables and early clinical evaluation of low-angle light scattering for platelet function analysis
The recently developed platelet aggregation technique based on low-angle light scattering (LaSca) in diluted platelet-rich...
Detection of Talaromyces marneffei in a HIV-infected patient from peripheral blood observation through Sysmex XN WNF/WNR channels
Detection of Talaromyces marneffei in a HIV-infected patient from peripheral blood observation through Sysmex XN WNF/WNR channels
This work was supported by the National Natural Science Foundation of China (82002215) and Natural Science Foundation of S...
Long-term safety profile of sutimlimab in adult Japanese patients with cold agglutinin disease
Long-term safety profile of sutimlimab in adult Japanese patients with cold agglutinin disease
Sutimlimab, a complement inhibitor, has recently been approved in Japan for treating cold agglutinin disease (CAD). We rep...
Improved survival among elderly patients with aggressive adult T-cell leukemia/lymphoma: Impact of mogamulizumab-containing chemotherapy
Improved survival among elderly patients with aggressive adult T-cell leukemia/lymphoma: Impact of mogamulizumab-containing chemotherapy
Due to the poor prognosis of adult T-cell leukemia/lymphoma (ATL), new treatments are urgently needed, especially for elde...
Therapy-related acute myeloid leukemia with inv(16)(p13.1q22)
Therapy-related acute myeloid leukemia with inv(16)(p13.1q22)
Conflict of interest The author has no conflict of interest. ...
Ruxolitinib for steroid-refractory chronic graft-versus-host disease: Japanese subgroup analysis of REACH3 study
Ruxolitinib for steroid-refractory chronic graft-versus-host disease: Japanese subgroup analysis of REACH3 study
Ruxolitinib, a Janus kinase (JAK1–JAK2) inhibitor, has demonstrated safety and efficacy in patients with graft-versu...
Long-term safety and efficacy of ropeginterferon alfa-2b in Japanese patients with polycythemia vera
Long-term safety and efficacy of ropeginterferon alfa-2b in Japanese patients with polycythemia vera
Ropeginterferon alfa-2b (ropegIFN), a new-generation interferon-based agent, has been approved in Japan for patients with ...
Long-term safety and effectiveness of romiplostim for chronic idiopathic thrombocytopenic purpura in real-world settings
Long-term safety and effectiveness of romiplostim for chronic idiopathic thrombocytopenic purpura in real-world settings
Idiopathic thrombocytopenic purpura (ITP), an autoimmune hematologic disorder characterized by severe platelet count reduc...
Silent inactivation of asparaginase in Japan: results of the prospective ALL-ASP19 trial
Silent inactivation of asparaginase in Japan: results of the prospective ALL-ASP19 trial
Silent inactivation (SI) of L-asparaginase (ASP) is a phenomenon by which a neutralizing antibody for ASP (AAA) decreases ...
Relationship between hemoglobinopathies and male infertility: a scoping review
Relationship between hemoglobinopathies and male infertility: a scoping review
Infertility is a common issue that threatens couples worldwide. Infertility can result from the male or female partner alo...
Adult-onset severe paroxysmal cold hemoglobinuria after COVID-19 successfully treated with sutimlimab
Adult-onset severe paroxysmal cold hemoglobinuria after COVID-19 successfully treated with sutimlimab
Paroxysmal cold hemoglobinuria (PCH) is a form of cold autoimmune hemolytic anemia characterized by the presence of the Do...
Expansion effect of romiplostim on hematopoietic stem and progenitor cells versus thrombopoietin and eltrombopag
Expansion effect of romiplostim on hematopoietic stem and progenitor cells versus thrombopoietin and eltrombopag
Romiplostim, a thrombopoietin (TPO) receptor agonist, is a clinically approved drug that is clearly effective in reconstit...
Immunohistochemical differentiation of extramedullary acute myeloid leukemia from blastic plasmacytoid dendritic cell neoplasm
Immunohistochemical differentiation of extramedullary acute myeloid leukemia from blastic plasmacytoid dendritic cell neoplasm
We extend our deepest appreciation to the entire medical team at Yokohama Municipal Citizen's Hospital for their unwaverin...
Newly diagnosed multiple myeloma with bleeding and coagulation abnormalities caused by a thrombin-inhibiting substance
Newly diagnosed multiple myeloma with bleeding and coagulation abnormalities caused by a thrombin-inhibiting substance
Approximately 7% of patients with newly diagnosed multiple myeloma (MM) experience bleeding complications with varying cau...
Splenic marginal zone lymphoma with prolymphocytic transformation and cyclin D1 expression in the absence of CCND1 rearrangement
Splenic marginal zone lymphoma with prolymphocytic transformation and cyclin D1 expression in the absence of CCND1 rearrangement
Splenic marginal zone lymphoma (SMZL) is one of the most common B-cell lymphomas that affect the spleen. We report a case ...
Mitochondrial dynamics as a potential therapeutic target in acute myeloid leukemia
Mitochondrial dynamics as a potential therapeutic target in acute myeloid leukemia
Acute myeloid leukemia (AML) cells are highly dependent on oxidative phosphorylation and the mitochondrial dynamics regula...
Pneumatic tube transport-induced pseudohyperkalemia in patients with extreme leukocytosis: a retrospective study from a single medical center
Pneumatic tube transport-induced pseudohyperkalemia in patients with extreme leukocytosis: a retrospective study from a single medical center
Pseudohyperkalemia (falsely elevated serum potassium) must be distinguished from true hyperkalemia to avoid unnecessary tr...
JSH practical guidelines for hematological malignancies, 2023: leukemia-3. Acute lymphoblastic leukemia/lymphoblastic lymphoma: ALL/LBL
JSH practical guidelines for hematological malignancies, 2023: leukemia-3. Acute lymphoblastic leukemia/lymphoblastic lymphoma: ALL/LBL
Conflict of interest KI has received per diem, including speaking f...
Comparison of disease and risk classifications of AML before and after incorporation of NGS analysis of bone marrow samples
Comparison of disease and risk classifications of AML before and after incorporation of NGS analysis of bone marrow samples
Mutation profiling by next-generation sequencing (NGS) has facilitated understanding of the molecular pathogenesis of acut...
阅读更多
format_indent_increase